InsiderClue
Insiders · Profile

Vivo Capital VIII, LLC

10% owner at Bolt Biotherapeutics · 10% owner at Aligos Therapeutics · 10% owner at Crinetics Pharmaceuticals · and 1 more. Filing since 25 Jan 2018. CIK 0001618789

BOLT Bolt Biotherapeutics, Inc. 10% owner · 10 trades ALGS Aligos Therapeutics, Inc. 10% owner · 2 trades CRNX Crinetics Pharmaceuticals, Inc. 10% owner · 14 trades YARW Yarrow Bioscience, Inc. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BOLT Bolt Biotherapeutics, Inc.
21 Nov 2023
10% owner
Sold at will
3,400
$3.06K
3.0%
BOLT Bolt Biotherapeutics, Inc.
20 Nov 2023
10% owner
Sold at will
54,700
$50.32K
32.6%
BOLT Bolt Biotherapeutics, Inc.
17 Nov 2023
10% owner
Sold at will
16,354
$15.21K
10.7%
BOLT Bolt Biotherapeutics, Inc.
16 Nov 2023
10% owner
Sold at will
15,000
$14.40K
9.5%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Bought
175,733
$3.51M
9.6%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Bought
150,000
$3.00M
opened
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Bought
24,267
$485.34K
9.6%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Sold, plan not stated
144
$2.88K
0.0%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Sold, plan not stated
62
$1.24K
0.0%
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
10% owner
Sold, plan not stated
20
$400.00
0.0%
ALGS Aligos Therapeutics, Inc.
20 Oct 2020
10% owner
Bought
483,267
$7.25M
18.4%
ALGS Aligos Therapeutics, Inc.
20 Oct 2020
10% owner
Bought
66,733
$1.00M
18.4%
CRNX Crinetics Pharmaceuticals, Inc.
17 Apr 2020
10% owner
Sold, plan not stated
84,598
$1.30M
22.1%
CRNX Crinetics Pharmaceuticals, Inc.
16 Apr 2020
10% owner
Sold, plan not stated
30,190
$458.89K
8.9%
CRNX Crinetics Pharmaceuticals, Inc.
15 Apr 2020
10% owner
Sold, plan not stated
215,810
$3.35M
40.8%
CRNX Crinetics Pharmaceuticals, Inc.
7 Apr 2020
10% owner
Sold, plan not stated
6,115
$86.83K
1.8%
CRNX Crinetics Pharmaceuticals, Inc.
3 Apr 2020
10% owner
Sold, plan not stated
300,000
$4.14M
46.9%
CRNX Crinetics Pharmaceuticals, Inc.
9 Mar 2020
10% owner
Sold, plan not stated
528
$10.30K
0.3%
CRNX Crinetics Pharmaceuticals, Inc.
10 Feb 2020
10% owner
Sold, plan not stated
7,555
$161.68K
4.3%
CRNX Crinetics Pharmaceuticals, Inc.
7 Feb 2020
10% owner
Sold, plan not stated
5,905
$129.91K
3.3%
CRNX Crinetics Pharmaceuticals, Inc.
4 Feb 2020
10% owner
Sold, plan not stated
13,460
$306.89K
7.0%
CRNX Crinetics Pharmaceuticals, Inc.
31 Jan 2020
10% owner
Sold, plan not stated
5,400
$117.18K
2.8%
CRNX Crinetics Pharmaceuticals, Inc.
30 Jan 2020
10% owner
Sold, plan not stated
7,600
$167.96K
3.8%
CRNX Crinetics Pharmaceuticals, Inc.
29 Jan 2020
10% owner
Sold, plan not stated
13,920
$309.02K
6.5%
CRNX Crinetics Pharmaceuticals, Inc.
20 Mar 2019
10% owner
Sold, plan not stated
417,000
$9.28M
66.5%
CRNX Crinetics Pharmaceuticals, Inc.
20 Jul 2018
10% owner
Bought
353,180
$6.58M
13.2%
YARW Yarrow Bioscience, Inc.
25 Jan 2018
10% owner
Bought
258,432
$4.39M
opened
YARW Yarrow Bioscience, Inc.
25 Jan 2018
10% owner
Bought
35,686
$606.66K
opened
28 decisions on file.